GlassScriptPhysician profile
Kim Ping Leung Stone
NPI 1649255159
$1,626.32
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $875 · 2020: $751.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $282.03 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $258.26 | 2019-2020 | |
| Allergan, INC. | $192.06 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.19 | 2019-2020 | |
| Abbvie INC. | $104.97 | 2019-2020 | |
| Amgen INC. | $88.25 | 2019-2020 | |
| Glaxosmithkline, LLC. | $75.28 | 2019-2020 | |
| Horizon Therapeutics Plc | $70.83 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $70.58 | 2019 | |
| Amarin Pharma, INC. | $64.24 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $62.37 | 2019 | |
| Merck Sharp & Dohme LLC | $45.71 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $35.49 | 2019-2020 | |
| Astellas Pharma US INC | $34.99 | 2019-2020 | |
| Esperion Therapeutics, INC. | $21.86 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $20.76 | 2019 | |
| Genentech USA, INC. | $19.68 | 2019 | |
| Seqirus USA INC | $16.94 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.31 | 2019 | |
| Pfizer INC. | $15.29 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.23 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kim Ping Leung Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.